PAM
CARM

Panagora Asset Management’s Carisma Therapeutics CARM Stock Holding History

Panagora Asset Management’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-313
Closed -$4K – 2572
2020
Q1 		$4K Buy
+313
New +$5.13K ﹤0.01% 2287
2018
Q3 		– Sell
-462
Closed -$18K – 2413
2018
Q2 		$18K Buy
+462
New +$20.4K ﹤0.01% 2200
2018
Q1 		– Sell
-174
Closed -$3K – 2348
2017
Q4 		$3K Sell
174
-826
-83% -$15.4K ﹤0.01% 2268
2017
Q3 		$32K Sell
1,000
-214
-18% -$5.98K ﹤0.01% 2122
2017
Q2 		$38K Hold
1,214
– – ﹤0.01% 2128
2017
Q1 		$53K Buy
+1,214
New +$50.6K ﹤0.01% 2005

Other funds holding CARM

TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return